<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the molecular genetic features and diagnostic aspects of <z:hpo ids='HP_0003745'>sporadic</z:hpo> Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) in children </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Tissue microarray was constructed to include 64 cases of pediatric <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and 6 cases of pediatric diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemistry and fluorescence in-situ hybridization for c-myc, bcl-2, bcl-6, IgH, myc/IgH and bcl-2/IgH gene were performed </plain></SENT>
<SENT sid="3" pm="."><plain>Cases of pediatric Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were subclassified into three groups based on their cellular orgins: the germinal center (GC) group, the late-germinal center (late-GC) group and the post-germinal center (post-GC) group </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among 64 Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> studied, expression of CD20, CD10, bcl-6, bcl-2 and MUM1 by immunohistochemistry were 100% (64 cases), 98.4% (63 cases), 96.9% (62 cases), 0 (0 cases) and 23.4% (15 cases), respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Various gene rearrangements were found involving the c-myc 93.1% (54/58 cases) and IgH 82.8% (48/58 cases) </plain></SENT>
<SENT sid="6" pm="."><plain>Detailed rearrangements are as follows: 46 cases (85.2%) myc/IgH gene translocation along with c-myc and IgH gene rearrangement; 4 cases (7.4%) c-myc gene rearrangement without IgH and myc/IgH abnormality; 4 cases (7.4%) without c-myc, IgH or myc/IgH gene rearrangement </plain></SENT>
<SENT sid="7" pm="."><plain>No case showed bcl-2 gene abnormality (100%) </plain></SENT>
<SENT sid="8" pm="."><plain>Fifty nine cases showed <z:mpath ids='MPATH_458'>normal</z:mpath> bcl-6 gene status </plain></SENT>
<SENT sid="9" pm="."><plain>One case had bcl-6 gene rearrangement and amplification with the pathologic and immunophenotypic characteristics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, leading to a revised pathological diagnosis of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, unclassifiable with features intermediate between diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="10" pm="."><plain>Two cases showed c-myc gene rearrangement </plain></SENT>
<SENT sid="11" pm="."><plain>Two cases showed bcl-6 gene amplification and 6 DLBCL cases had a <z:mpath ids='MPATH_458'>normal</z:mpath> status of bcl-2/IgH </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: A majority of pediatric <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> arise from the germinal center B cells, most of which have c-myc gene rearrangement </plain></SENT>
<SENT sid="13" pm="."><plain>It is useful to distinguish <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> by multiple genes detection </plain></SENT>
</text></document>